PainReform Ltd. (PRFX): Price and Financial Metrics
PRFX Price/Volume Stats
| Current price | $5.30 | 52-week high | $80.64 |
| Prev. close | $11.16 | 52-week low | $1.73 |
| Day low | $4.55 | Volume | 2,938,800 |
| Day high | $7.87 | Avg. volume | 832,485 |
| 50-day MA | $2.94 | Dividend yield | N/A |
| 200-day MA | $13.17 | Market Cap | 768.50K |
PRFX Stock Price Chart Interactive Chart >
PainReform Ltd. (PRFX) Company Bio
PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
PRFX Price Returns
| 1-mo | 65.63% |
| 3-mo | 71.83% |
| 6-mo | -53.99% |
| 1-year | -92.49% |
| 3-year | -98.59% |
| 5-year | N/A |
| YTD | -91.97% |
| 2023 | -33.37% |
| 2022 | -68.97% |
| 2021 | -70.25% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...